How are Michael Jackman’s restricted share units in Nano-X (NNOX) structured?

The ordinary shares in one row represent restricted share units granted on December 10, 2025. These units vest in twelve equal monthly installments, becoming fully vested on the one-year anniversary of the grant date, according to the disclosure footnote.

Nano-X director Jackman reports initial holdings

Nano-X Imaging Ltd. director Michael Jackman filed an initial ownership report showing his existing equity stake in the company.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Nano-X Imaging Ltd. director Michael Jackman filed an initial ownership report showing his existing equity stake in the company. He holds stock options covering 19,624 ordinary shares at an exercise price of $2.2100 per share, expiring on November 25, 2029, which are fully vested and exercisable. He also reports direct ownership of ordinary shares, including shares underlying restricted share units granted on December 10, 2025 that vest in twelve equal monthly installments over one year.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Jackman Michael

Role Director

Type	Security	Shares	Price	Value
holding	Stock Option (right to buy ordinary shares)	--	--	--
holding	Ordinary shares	--	--	--
holding	Ordinary shares	--	--	--

Holdings After Transaction: Stock Option (right to buy ordinary shares) — 19,624 contracts (Direct); Ordinary shares — 25,337 shares (Direct)

Footnotes (2)

F1. The ordinary shares reported in this row consist of shares underlying restricted share units that were granted to the Reporting Person on December 10, 2025 and that vest in twelve equal monthly installments such that they will be fully vested upon the one-year anniversary of the grant date.
F2. The options reported in this row were granted to the Reporting Person by the Issuer on November 25, 2019 and are fully vested and exercisable as of the date of this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Nano-X Imaging (NNOX) director Michael Jackman report in this Form 3?

Michael Jackman reports his existing equity holdings in Nano-X Imaging. The filing lists his stock options and ordinary share positions, including restricted share units that vest monthly over one year from a December 2025 grant.

How many Nano-X Imaging (NNOX) shares are covered by Michael Jackman’s stock options?

His options cover 19,624 Nano-X Imaging ordinary shares. These options were granted in November 2019, are fully vested and exercisable, and carry an exercise price of $2.2100 per share with an expiration date in November 2029.

What is the exercise price and expiration date of Michael Jackman’s Nano-X (NNOX) options?

His stock options have an exercise price of $2.2100 per ordinary share and expire on November 25, 2029. According to the disclosure, the options are already fully vested and exercisable as of the report date.

Does Michael Jackman’s Nano-X (NNOX) Form 3 show any open-market stock trades?

The Form 3 does not show any open-market purchases or sales. It only lists his existing holdings in stock options and ordinary shares, including restricted share units that vest over time, with no new trading activity reported.

What ownership type does Michael Jackman report for his Nano-X (NNOX) holdings?

He reports direct ownership of both his stock options and ordinary shares. The filing does not attribute these positions to any trust or external entity, indicating they are held directly in his name as a company director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/18/2026 - 11:28 AM EDT

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Jackman Michael

(Last)

(First)

(Middle)

C/O NANO-X IMAGING LTD., OFER TECH PARK

94 SHLOMO SHMELTZER ROAD

(Street)

PETACH TIKVA

4970602

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Nano-X Imaging Ltd. [ NNOX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary shares	7,793	D
Ordinary shares⁽¹⁾	17,544	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (right to buy ordinary shares)	⁽²⁾	11/25/2029	Ordinary shares	19,624	$2.21	D

Explanation of Responses:

1. The ordinary shares reported in this row consist of shares underlying restricted share units that were granted to the Reporting Person on December 10, 2025 and that vest in twelve equal monthly installments such that they will be fully vested upon the one-year anniversary of the grant date.

2. The options reported in this row were granted to the Reporting Person by the Issuer on November 25, 2019 and are fully vested and exercisable as of the date of this report.

Remarks:

Exhibit 24.1 Power of Attorney

	/s/ Marina Gofman Feler, attorney-in-fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR